Diether Lambrechts

Citée par

	Toutes	Depuis 2018
Citations	55338	29708
indice h	114	89
indice i10	405	360

7000

3500

1750

5250

20042005200620072008200920102011201220132014201520162017201820192020202120222023166 228 333 382 482 619 793 1310 2053 2809 3268 3787 4380 4408 4749 5055 5680 6567 6975 653

Accès public

Tout afficher

394 articles

30 articles

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Peter Carmeliethoogleraar, Universiteit van Leuven, VIBAdresse e-mail validée de kuleuven.vib.be
Bram BoeckxVIB - KULAdresse e-mail validée de vib-kuleuven.be
Ignace VergoteProfessor of Gynecologic Oncology, University of LeuvenAdresse e-mail validée de uzleuven.be
hans wildiershoogleraar UZLeuvenAdresse e-mail validée de uzleuven.be
Bernard ThienpontLaboratory of Functional Epigenetics - KULeuven, BelgiumAdresse e-mail validée de kuleuven.be
Christos SotiriouUniversité Libre de BruxellesAdresse e-mail validée de bordet.be
Massimiliano MazzoneGroup Leader, Vesalius Research CenterAdresse e-mail validée de vib-kuleuven.be
Christine DesmedtKU LeuvenAdresse e-mail validée de kuleuven.be
Adrian ListonBabraham InstituteAdresse e-mail validée de babraham.ac.uk
Ludo Van Den BoschKU Leuven & VIBAdresse e-mail validée de kuleuven.vib.be
Dirk TimmermanProfessor Gynecology, KU Leuven; Visiting Professor Imperial College London; Sacro Cuore RomeAdresse e-mail validée de uzleuven.be
Stein AertsProfessor @ University of Leuven; VIB Group LeaderAdresse e-mail validée de kuleuven.be
Junbin QianWomen's Hospital, School of Medicine, Zhejiang UniversityAdresse e-mail validée de zju.edu.cn
Frederik De SmetProfessor, KULeuvenAdresse e-mail validée de kuleuven.be
Bart GhesquiereHead of Metabolomics Expertise Center, KULeuven-VIBAdresse e-mail validée de kuleuven.vib.be
Philip Van DammeProfessor of Neuroscience, University of LeuvenAdresse e-mail validée de uzleuven.be
Line HeylenZiekenhuis Oost-LimburgAdresse e-mail validée de uhasselt.be
Cedric BlanpainDirector of the Laboratory of Stem Cells and CancerAdresse e-mail validée de ulb.be
Sherene LoiPeter MacCallum Cancer Centre, Melbourne, AustraliaAdresse e-mail validée de petermac.org
Bart De Stroopergewoon hoogleraar KU Leuven en onderzoeksdirecteur VIBAdresse e-mail validée de cme.vib-kuleuven.be

Suivre

Diether Lambrechts

Laboratory for Translational Genetics, Department of Oncology, VIB and KULeuven, Leuven, Belgium

Adresse e-mail validée de vib-kuleuven.be

single-cell


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective … W De Roock, B Claes, D Bernasconi, J De Schutter, B Biesmans, ... The lancet oncology 11 (8), 753-762, 2010	2421	2010
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study BF Voight, GM Peloso, M Orho-Melander, R Frikke-Schmidt, M Barbalic, ... The Lancet 380 (9841), 572-580, 2012	2330	2012
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease H Schunkert, IR König, S Kathiresan, MP Reilly, TL Assimes, H Holm, ... Nature genetics 43 (4), 333-338, 2011	2005	2011
Large-scale genotyping identifies 41 new loci associated with breast cancer risk K Michailidou, P Hall, A Gonzalez-Neira, M Ghoussaini, J Dennis, ... Nature genetics 45 (4), 353-361, 2013	1195	2013
Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial TS Maughan, RA Adams, CG Smith, AM Meade, MT Seymour, RH Wilson, ... The Lancet 377 (9783), 2103-2114, 2011	1186	2011
VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death D Lambrechts, E Storkebaum, M Morimoto, J Del-Favero, F Desmet, ... Nature genetics 34 (4), 383-394, 2003	1083	2003
Gene prioritization through genomic data fusion S Aerts, D Lambrechts, S Maity, P Van Loo, B Coessens, F De Smet, ... Nature biotechnology 24 (5), 537-544, 2006	1058	2006
Association analysis identifies 65 new breast cancer risk loci K Michailidou, S Lindström, J Dennis, J Beesley, S Hui, S Kar, A Lemaçon, ... Nature 551 (7678), 92-94, 2017	1049	2017
Role of PlGF in the intra-and intermolecular cross talk between the VEGF receptors Flt1 and Flk1 M Autiero, J Waltenberger, D Communi, A Kranz, L Moons, D Lambrechts, ... Nature medicine 9 (7), 936-943, 2003	983	2003
Phenotype molding of stromal cells in the lung tumor microenvironment D Lambrechts, E Wauters, B Boeckx, S Aibar, D Nittner, O Burton, ... Nature medicine 24 (8), 1277-1289, 2018	927	2018
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies XR Yang, J Chang-Claude, EL Goode, FJ Couch, H Nevanlinna, RL Milne, ... Journal of the National Cancer Institute 103 (3), 250-263, 2011	793	2011
Polygenic risk scores for prediction of breast cancer and breast cancer subtypes N Mavaddat, K Michailidou, J Dennis, M Lush, L Fachal, A Lee, JP Tyrer, ... The American Journal of Human Genetics 104 (1), 21-34, 2019	670	2019
VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection E Storkebaum, D Lambrechts, P Carmeliet Bioessays 26 (9), 943-954, 2004	664	2004
Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer KL Bolton, G Chenevix-Trench, C Goh, S Sadetzki, SJ Ramus, BY Karlan, ... Jama 307 (4), 382-389, 2012	656	2012
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ... Nature genetics 45 (4), 371-384, 2013	608	2013
Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS E Storkebaum, D Lambrechts, M Dewerchin, MP Moreno-Murciano, ... Nature neuroscience 8 (1), 85-92, 2005	604	2005
Thrombomodulin mutations in atypical hemolytic–uremic syndrome M Delvaeye, M Noris, A De Vriese, CT Esmon, NL Esmon, G Ferrell, ... New England Journal of Medicine 361 (4), 345-357, 2009	597	2009
Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer K Michailidou, J Beesley, S Lindstrom, S Canisius, J Dennis, MJ Lush, ... Nature genetics 47 (4), 373-380, 2015	591	2015
Prediction of breast cancer risk based on profiling with common genetic variants N Mavaddat, PDP Pharoah, K Michailidou, J Tyrer, MN Brook, MK Bolla, ... JNCI: Journal of the National Cancer Institute 107 (5), 2015	579	2015
Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene W Janssens, R Bouillon, B Claes, C Carremans, A Lehouck, I Buysschaert, ... Thorax 65 (3), 215-220, 2010	579	2010

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs